BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• BioMidwest

  MedPro Imaging to Repair GE E8/E9 Ultrasound Transducers

  October 11, 2011

   · 

  2 min read
• BioForest

  10th Annual Biotechnology Industry Organization (BIO) Investor Forum Business Roundtables Highlight Innovative Strategies in Deal-Making and Investments

  October 11, 2011

   · 

  1 min read
• Drug Development

  Merrimack Pharmaceuticals Inc. Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients

  October 11, 2011

   · 

  1 min read
• Drug Development

  Boston Therapeutics, Inc. to Start Clinical Trial in Type 2 Diabetes

  October 11, 2011

   · 

  1 min read
• Significant Reduced Loss of Brain Volume in Multiple Sclerosis Patients Treated with Teva Pharmaceutical Industries Limited’s COPAXONE(R)

  October 11, 2011

   · 

  1 min read
• Pharma IQ Release: Establishing the Correct QbD Strategies and Tools Early in the Development Process is Key to Ensuring We Have Robust Quality Products Downstream

  October 11, 2011

   · 

  1 min read
• Biotech Beach

  Aeolus Pharmaceuticals Inc. Announces $12.7 Million National Institutes of Health (NIH) Counteract Grant Award to Continue Development of AEOL 10150 as a Treatment Against Chlorine and Sulfur Mustard Gas Exposure

  October 11, 2011

   · 

  7 min read
• Drug Development

  Agennix AG Announces Data From Talactoferrin Phase II Trial in Non-Small Cell Lung Cancer Published in Journal of Clinical Oncology

  October 11, 2011

   · 

  6 min read
• Business

  Precise Biometrics AB and NXP Semiconductors Enter Partnership

  October 11, 2011

   · 

  1 min read
• Drug Development

  Pevion Biotech AG’s Therapeutic Candida Vaccine Shows Robust Systemic and Mucosal Immunogenicity, While Epidemiological Survey Confirms Excellent Market Potential

  October 11, 2011

   · 

  5 min read